findmyKOL
Clinical trialNCT03592472RecruitingPhase 3Interventional

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

SponsorXynomic Pharmaceuticals, Inc.Enrollment413Renal Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Beijing Cancer Hospital

    Beijing, China

    Recruiting
  • Zhongshan Hospital Affiliated To Fudan University

    Shanghai, China

    Not, yet, recruiting
Italy
  • Fondazione del Piemonte Per L'Oncologia_istituto Di Candiolo, Irccs_ Oncologia Medica

    Candiolo, Italy

    Withdrawn
  • A.O. Cannizzaro_uos Oncologia Medica

    Catania, Italy

    Withdrawn
  • Irccs Istituto Scientifico Romagnolo Per Lo Studio E la Cura Dei Tumori (irst) Uo Oncologia Medica

    Meldola (FC), Italy

    Withdrawn
  • Istituto Europeo Di Oncologia_unità Oncologia Medica Urogenitale E Cervico Facciale

    Milan, Italy

    Withdrawn
  • Istituto Nazionale Dei Tumori-Fondazione Pascale- Sc Oncologia Medica

    Naples, Italy

    Withdrawn
  • Azienda Ospedaliero-Universitaria Maggiore Della Carità Novara_sc Oncologia Medica

    Novara, Italy

    Withdrawn
  • Istituti Clinici Scientifici Maugeri Spa-Sb_ Uo Oncologia Medica

    Pavia, Italy

    Withdrawn
  • Azienda Ospedaliero Universitaria Pisana_ Uo Oncologia Medica Universitaria

    Pisa, Italy

    Withdrawn
  • Fondazione Policlinico Universitario A. Gemelli, U.O.C. Oncologia Medica

    Roma, Italy

    Withdrawn
Poland
  • Szpital Specjalistyczny W Brzozowie Podkarpacki Osrodek Onkologiczny

    Brzozów, Poland

    Withdrawn
  • Szpitale Pomorskie Sp. Z O.O. Oddział Onkologii I Radioterapii

    Gdynia, Poland

    Withdrawn
  • Szpital Specjalistyczny Im. Ludwika Rydygiera W Krakowie Sp. Z O.O. Oddział Onkologii Klinicznej Z Pododdziałem Dziennym

    Krakow, Poland

    Completed
  • Clinical Research Center Sp. Z O.O., Medic-R Sp. K.

    Poznan, Poland

    Withdrawn
South Korea
  • National Cancer Center - Center for Prostate Cancer

    Goyang-si, South Korea

    Completed
  • Cha Bundang Medical Center, Cha University

    Seongnam-si, South Korea

    Completed
  • Asan Medical Center - University of Ulsan College of Medicin

    Seoul, South Korea

    Completed
  • Samsung Medical Center - Hematology-Oncology

    Seoul, South Korea

    Withdrawn
  • Severance Hospital, Yonsei University Health System - Medical Oncology

    Seoul, South Korea

    Completed
Spain
  • H.G.U. de Elche

    Elche, Spain

    Withdrawn
  • Hospital Universitario 12 de Octubre

    Madrid, Spain

    Completed
  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, Spain

    Withdrawn
  • H.U. Virgen de la Victoria

    Málaga, Spain

    Withdrawn
United States
  • University of Ua Cancer Center(uacc)/dh-Sjhmc

    Phoenix, Arizona, United States

    Withdrawn
  • University of California Davis Comprehensive Cancer Center

    Sacramento, California, United States

    Withdrawn
  • Ucsf Helen Diller Family Comphrensive Cancer Center - Hemato

    San Francisco, California, United States

    Withdrawn
  • Norton Cancer Institute, Norton Healthcare Pavilion

    Louisville, Kentucky, United States

    Completed
  • Ochsner Clinic Foundation

    New Orleans, Louisiana, United States

    Completed
  • Gu Research Network/urology Cancer Center

    Omaha, Nebraska, United States

    Withdrawn
  • Nebraska Cancer Specialists

    Omaha, Nebraska, United States

    Completed
  • Northwell Health/monter Cancer Center

    Lake Success, New York, United States

    Withdrawn
  • Mainstreet Physicans Care

    Rochester, New York, United States

    Completed
  • Precision Cancer Research/dayton Physicians Network - Treatment

    Kettering, Ohio, United States

    Withdrawn
  • Oregon Health and Science University

    Portland, Oregon, United States

    Completed
  • St. Luke'S Hospital

    Easton, Pennsylvania, United States

    Completed
  • Hope Cancer Center of East Texas

    Tyler, Texas, United States

    Completed
  • Medical Oncology Associates, Ps (dba Summit Cancer Centers)

    Spokane, Washington, United States

    Withdrawn

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Jul 2018
Primary completion
30 Dec 2026
Completion
30 Jun 2028
Last update posted
13 Apr 2025
Registered enrollment
413
Registry id
NCT03592472

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.